C. Fangyun Wu

Jul 1, 2024 | jrheum.org | Sanjana Tarannum |Jessica Widdifield |C. Fangyun Wu |Sindhu R Johnson

Key Indexing Terms:disease-modifying antirheumatic drugspain medicationspsoriatic arthritisrheumatoid arthritissex differencesEarly initiation of disease-modifying antirheumatic drugs (DMARDs) is the cornerstone of therapy in both rheumatoid arthritis (RA) and psoriatic arthritis (PsA), leading to improved disease outcomes.1,2 Various aspects of these inflammatory forms of arthritis are associated with the sex of the patient.

May 9, 2024 | jrheum.org | Sanjana Tarannum |Jessica Widdifield |C. Fangyun Wu |Sindhu R Johnson

Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study Sanjana Tarannum, Jessica Widdifield, C. Fangyun Wu, Sindhu R. Johnson, Paula Rochon, Lihi Eder The Journal of Rheumatology May 2024, jrheum.2023-1148; DOI: 10.3899/jrheum.2023-1148